Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Balance Tablet
- Development stage
- Phase 4
- Lead developer
- General Authority for Teaching Hospitals and Institutes
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Balance Tablet is a comprehensive multivitamin and mineral supplement designed to prevent and reduce micronutrient deficiencies. It is currently being evaluated in a Phase 4 clinical trial sponsored by the General Committee of Teaching Hospitals and Institutes in Egypt. The study specifically focuses on obese adults undergoing weight loss treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic) and liraglutide (Saxenda). These patients are at an increased risk of vitamin and mineral deficiencies due to chronic appetite suppression and reduced caloric intake, similar to the biochemical changes observed after metabolic and bariatric surgery. The tablet contains a broad range of essential nutrients, including vitamins A, B-complex, C, D, E, and K, as well as minerals like calcium, iron, zinc, magnesium, and selenium, at doses intended to maintain nutritional homeostasis.
- Brand names
- Balance Tablet
- Other names
- Balanced nutritional tabletsBalance multivitamin tablets
02
Targets
RXRA (Retinoid X receptor alpha)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Balance Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Balance Tablet.